US Congress House Bill 2439 (Prior Session Legislation)

---

Spectrum: Strong Partisan Bill (Democrat 23-2)
Status: Introduced on May 16 2017 - 25% progression, died in committee
Action: 2017-05-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Fair Accountability and Innovative Research Drug Pricing Act of 2017 This bill amends the Public Health Service Act to require manufacturers of certain drugs and biological products with a wholesale cost of $100 or more per month to report to the Department of Health and Human Services (HHS) price increases that result in a 10% or more increase in the cost of a drug over a 12-month period or a 25% or more increase over a 36-month period. Reports are required for prescription drugs and drugs commonly administered in hospitals, except vaccines, drugs for rare conditions, and drugs with annual sales for Medicare and Medicaid enrollees of less than $1. Reports must contain specified information including pricing history and a justification for each price increase in the relevant period. Manufacturers that do not submit a required report are subject to a civil penalty. Collected penalty funds must be used to carry out activities related to this reporting requirement and to improve consumer and provider information about drug value and drug price transparency. HHS must publish manufacturer reports, a summary of those reports, and supporting analyses.

Fair Accountability and Innovative Research Drug Pricing Act of 2017

Rep. Janice Schakowsky [D-IL]	Rep. Rosa DeLauro [D-CT]	Rep. Lloyd Doggett [D-TX]	Rep. Elijah Cummings [D-MD]
Sen. Peter Welch [D-VT]	Rep. John Yarmuth [D-KY]	Rep. Kathy Castor [D-FL]	Rep. Steve Cohen [D-TN]
Rep. Chellie Pingree [D-ME]	Rep. Michelle Lujan Grisham [D-NM]	Rep. Michael Doyle [D-PA]	Rep. Timothy Walz [D-MN]
Rep. Mark Pocan [D-WI]	Rep. Eleanor Norton [D-DC]	Rep. Bennie Thompson [D-MS]	Rep. Emanuel Cleaver [D-MO]
Rep. Judy Chu [D-CA]	Rep. Sheila Jackson-Lee [D-TX]	Rep. Raul Grijalva [D-AZ]	Rep. Jamie Raskin [D-MD]
Rep. Ro Khanna [D-CA]	Rep. Francis Rooney [R-FL]	Rep. Betty McCollum [D-MN]	Rep. Peter King [R-NY]
Rep. Ted Lieu [D-CA]

Date	Chamber	Action
2017-05-19	House	Referred to the Subcommittee on Health.
2017-05-16	House	Referred to the House Committee on Energy and Commerce.
2017-05-16	House	Introduced in House

SB1131 (Related) 2017-05-16 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/house-bill/2439/all-info
Text	https://www.congress.gov/115/bills/hr2439/BILLS-115hr2439ih.pdf